Clinical trial Recruiting at 4 sites Interventional Ages 21 and up Women only

Exercise plus cognitive behavioural therapy for fatigue in women treated for breast cancer in Singapore

Official title: Pilot Study of Exercise Therapy and Cognitive Behavioural Therapy for Fatigue in Female Cancer Patients in Singapore

Run by National Cancer Centre, Singapore · NCT07116161 · Data updated 2026-11-12

This program tests whether graded exercise combined with cognitive behavioural therapy can reduce fatigue and help women with breast cancer stay on their treatment plans.

Quick facts

Study typeInterventional
Ages21 Years and up
SexWomen only
Enrollment100 (estimated)
SponsorNational Cancer Centre, Singapore
Academic / other
Drugs / interventionschemotherapy, immunotherapy
Locations4 sites (Singapore and 3 other locations)
StatusRecruiting
StartedJuly 14, 2025
Main results expectedApril 30, 2027
Study endsDecember 31, 2027
Registry record updatedMay 29, 2026
Trial IDNCT07116161 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are English-speaking women aged 21 or older with stage I–III breast cancer who have completed surgery (and adjuvant chemotherapy if indicated) and report significant fatigue (one-item fatigue score ≥4).

Probably not a fit

Patients who are pregnant or lactating, medically unable to undertake graded exercise, do not report significant fatigue, or cannot attend in-person visits or communicate in English are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, controlled pilot intervention enrolling 100 women across National Cancer Centre Singapore, Singapore General Hospital and NCCS satellite clinics to test graded exercise therapy with or without added cognitive behavioural therapy. Ninety participants form the primary cohort (stage I–III who have completed surgery and adjuvant chemotherapy if indicated) and ten form an exploratory cohort (stage IV on systemic therapy). Participants are screened using routine referrals, the distress thermometer, and a one-item fatigue scale (score ≥4) and provide informed consent before randomization. Primary outcomes include acceptability, feasibility, fatigue levels, and treatment adherence over the study period.

Why it matters

Potential benefit: If successful, combining graded exercise and CBT could meaningfully reduce cancer-related fatigue and improve adherence to breast cancer treatments and daily functioning.

How similar studies have gone: Prior trials have shown that exercise programs and cognitive behavioural therapy can each reduce cancer-related fatigue, though combining them in this specific Singapore clinical setting is being tested here.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Primary cohort (N=90):

1. Female
2. ≥21 years of age
3. Stage I-III breast cancer regardless of hormone receptor status or human epidermal growth factor receptor 2 (HER2) status
4. Completed surgery
5. Completed adjuvant chemotherapy, if indicated
6. Reported fatigue (One-item fatigue scale score ≥ 4)
7. Ability to read and communicate in English
8. Willing to provide informed consent for the study participation

Exploratory cohort (N=10):

1. Female
2. ≥21 years of age
3. Stage IV breast cancer regardless of hormone receptor status or human epidermal growth factor receptor 2 (HER2) status
4. Completed surgery
5. Currently receiving systemic therapy (e.g. endocrine therapy, chemotherapy, targeted therapy or immunotherapy)
6. Reported fatigue (One-item fatigue scale score ≥ 4)
7. Ability to read and communicate in English
8. Willing to provide informed consent for the study participation

Exclusion Criteria for both cohorts:

1. Pregnant or lactating
2. Presence of dementia or major psychiatric disease
3. Deemed medically unsuitable by medical team for low to moderate intensity exercise
4. Unable or unwilling for tele-counselling sessions
5. Uncontrolled pain or undiagnosed pain
6. Low blood counts: Hb \<8.0, Platelet \<50K, ANC \<1
7. Electrolyte imbalances: K \<3.0, Na \<130
8. Cardiovascular diseases, including but not limited to: LVEF \<35%, uncontrolled arrhythmias, severe coronary artery disease, severe valvular heart disease, uncontrolled hypertension etc. not cleared by a cardiologist
9. Active infection
10. Currently engaged in moderate to vigorous physical activity

Where it's running

  • National Cancer Centre, Singapore (NCCS)
    Singapore, Singapore
    Recruiting
  • Singapore General Hospital
    Singapore, Singapore
    Recruiting
  • NCCS Satellite Clinic @ Changi General Hospital
    Singapore, Singapore
    Recruiting
  • NCCS Satellite Clinic @ Sengkang General Hospital
    Singapore, Singapore
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.